C4 Therapeutics Inc

Small-Cap Stocks Penny Stocks Biotech Stocks Healthcare Stocks

$3.63

-0.05 (-1.36%)

As of May 16, 2:07 AM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 13 93%

Hold 1 7%

Sell 0 0%

Price Target

Analyst Price Target +981.0% upside

Low Target $29.92

Average Target $39.24

High Target $50.68

Current Price $3.63

Current
$3.63

Target
$39.24

$29.92 $39.24 avg $50.68

Scenario Analysis

Bear Case

$29.92

724.2%

Low target

Base Case

$39.24

+981.0%

Avg target

Bull Case

$50.68

+1,296.1%

High target

Risk/Reward

1.8x

Balanced

Price in Context

52-Week High

$3.95

-8.1% from high

52-Week Low

$1.21

+200.0% from low

Target vs 52W High

$39.24

+893.4% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	75%	$257.58	+22.4%
AMGN Amgen Inc	Hold	44	48%	$190.87	-41.5%
GILD Gilead Sciences Inc	Strong Buy	39	79%	$362.68	+179.9%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	+0.3%
REGN Regeneron Pharmaceuticals	Strong Buy	38	79%	$76.80	-89.0%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-64.3%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-21.7%
BIIB Biogen Inc	Buy	43	56%	$91.45	-52.6%